Skip to content
  • Sunday, 26 July 2026
  • 3:19 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Loss of TDP-43 in microglia linked to neurological disease development
Biotech & Genetic Research

Loss of TDP-43 in microglia linked to neurological disease development

Jia Lissa Jul 14, 2026 0

Researchers at the University of Lausanne (Unil) in Switzerland have made a groundbreaking discovery, identifying a previously unrecognized role for…

Read More
Neuroscience & Brain Research

Discovery of Foamy Microglia Linked to Rapid Multiple Sclerosis Progression and Failed Brain Repair Mechanisms

Rifan Muazin Jun 30, 2026 0

A collaborative research effort led by Daan van der Vliet and scientists from the Netherlands Institute for Neuroscience, Leiden University,…

Read More
Neuroscience & Brain Research

Scientists Uncover the Biological Mechanism Behind Lecanemab and the Role of Microglia in Clearing Alzheimers Plaques

Rifan Muazin Apr 4, 2026 0

Lecanemab, a monoclonal antibody treatment marketed under the brand name Leqembi, represents a significant milestone in the clinical management of…

Read More
Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce CompetitionBrainstem Neural Circuitry Identified as Key Driver of Hypertension Offering New Avenues for Targeted TreatmentUCSF Researchers Discover Lungs as a Major Site of Blood Production and Source of Hematopoietic Stem CellsMoving beyond the binary: how the convergence of small and large molecules is reshaping pharmaceutical R&D
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ